Overview

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
To assess the pharmacodynamic effects of co-administrated SK3530 (PDE5 inhibitor) and Amlodipine, phase I study in Hypertensive patient was designed.
Phase:
Phase 1
Details
Lead Sponsor:
SK Chemicals Co., Ltd.
SK Chemicals Co.,Ltd.
Treatments:
Amlodipine